Skip navigation

Zoetis Inc.

N/A : ZTS
Pharmaceuticals
Florham Park NJ
2013 Revenue (US$ Millions)$4,561
2012 Revenue (US$ Millions)$4,336
Revenue Growth (%)5.19%
Net Income (US$ Millions)$504
Common Shares Outstanding (Millions)$500
Earnings Per Share (US$)$1.01
Price To Earnings Ratio34.64
Total Equity (US$ Millions)$940
Profit Margin (%)11.05%
Return On Equity (%)12.52%
Long Term Debt (US$ Millions)$3,642
Debt To Equity Ratio (%)3.87%
Market Capitalization (US$ Millions)$16,345
Total Assets (US$ Millions)$6,558
Return on Assets (%)8.05
Current Assets (US$ Millions)$3,357
Inventories (US$ Millions)$1,293
Current Liabilities (US$ Millions)$1,415
Cost of Goods Sold (US$ Millions)$1,669
Asset Turnover0.7
Inventory Turnover1.27
ExchangeN/A